检索结果-南通市图书馆

Purifying chylous plasma by precluding triglyceride via carboxylated polyethersulfone microfiltration membrane

Chinese Journal of Chemical Engineering 2022年第9期35卷 130-139页

作者： Yang Liu Qiu Han Guiliang Li Haibo Lin Fu Liu Gang Deng dingfeng lv Weijie Sun Ningbo Institute of Materials Technology&Engineering Chinese Academy of SciencesNingbo 315000China University of Chinese Academy of Sciences Beijing 100049China The Ningbo Central Blood Station Ningbo 315099China Department of Blood Transfusion Ningbo First HospitalNingbo 315010China

Precluding the excessive lipoproteins from plasma rapidly and effectively is highly needed for biomedical detection and reducing plasma product scrap in blood donation stations.The current centrifugation procedure is high-cost and time-consuming.Herein,we fabricated an anionic microfiltration polyethersulfone(PES)membrane modified by interface swelling and implanting of acrylic acid(AA)for screening out large particle lipoprotein chylomicron(CM)and adsorbing cationic very low-density lipoproteins(VLDL).To improve the separation efficiency,a two-stage filtration through carboxylated polyethersulfone microfiltration membranes with the mean pore size of 0.45 and 0.22μm respectively were conducted.Attenuated total reflection Fourier transform infrared technique(ATR-FTIR),water contact angle(WCA),Zeta potential and scanning electron microscope(SEM)were employed to characterize the modified membrane.To test the effectiveness of this membrane,plasma flux and concentration variation of plasma components were examined to study the purification effectiveness.Furthermore,the hemocompatibility of modified membranes was tested to confirm its practicability on bloodcontacting materials.The carboxylated polyethersulfone microfiltration membrane shows its promising potential application to purify chylous plasma.

关键词： Chylous plasma Chylomicrons Very low-density lipoproteins Carboxylated polyethersulfone microfiltration membrane

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Thioredoxin-1 nuclear translocation by IL-6/STAT3 signaling promotes epithelial-mesenchymal transition and metastasis of colorectal cancer through upregulation of S100P

Thioredoxin-1 nuclear translocation by IL-6/STAT3 signaling ...

引用

2019年浙江省检验医学学术大会

作者： Aihua Wu Lei Jiang dingfeng lv Yijun Mo Yanqing Liu Ningbo First Hospital The First Affiliated Hospital of Wenzhou Medical University

Background & Aims: Cytokine IL-6 and redox regulator Trx-1 can contribute to EMT and promote metastasis of CRC progression. Phosphorylation STAT3 and Trx-1 translocated into nuclear thereby regulating target gene tran...

关键词：

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

重油催化裂解在炼化企业布局影响因素研究

引用

中外能源 2024年第5期29卷 75-81页

作者：吕清龙孙会东邢定峰张晓华佘志鸿中国石油天然气股份有限公司规划总院北京100083

随着我国炼化产业的快速发展,原油一次能力已接近10×10^(8)t/a,但汽柴油消费总量受经济结构转型、新能源替代等因素影响,汽油需求量即将达峰,柴油需求量已呈现下降趋势。与之相对应的,乙烯、丙烯的下游化工产品未来仍有一定增长空间。... 详细信息

随着我国炼化产业的快速发展,原油一次能力已接近10×10^(8)t/a,但汽柴油消费总量受经济结构转型、新能源替代等因素影响,汽油需求量即将达峰,柴油需求量已呈现下降趋势。与之相对应的,乙烯、丙烯的下游化工产品未来仍有一定增长空间。重油催化裂解装置相较常规催化裂化可大幅减少汽柴油产量、增产化工原料,已成为炼化企业实现“减油增化”转型升级的重要路径之一。在具体项目布局规划时,由于炼化企业装置结构、所处地域市场条件等情况不同,分析企业是否适宜布局该装置是决策者的主要难点。结合催化裂解技术特点,总结分析了“企业所在地油品过剩程度、减油增化程度、化工品目标市场、资源利用程度、苯资源平衡、催化裂解原料性质、存量资产利用程度、投资回报率”共八项影响重油催化裂解项目决策实施的主要因素,为投资决策者提供支持依据。

关键词：催化裂解减油增化影响因素

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

CMV-DNA和IgM抗体检测对慢性重型乙型肝炎患者活动性巨细胞病毒感染的诊断价值评估

引用

现代实用医学 2017年第3期29卷 292-294,421页

作者：褚金国吕定丰相代荣钱国清谢一潋李国祥宁波市第一医院宁波315010 浙江大学医学院附属第一医院

目的评估CMV-DNA和IgM抗体检测对慢性重型乙型肝炎患者活动性巨细胞病毒感染的诊断价值。方法 100例慢性重型乙型肝炎(CSHB)患者采用免疫组化二步法检测CMV-pp65抗原、荧光定量PCR法检测CMV-DNA及酶联免疫吸附反应法(ELISA)检测CMV-IgM... 详细信息

目的评估CMV-DNA和IgM抗体检测对慢性重型乙型肝炎患者活动性巨细胞病毒感染的诊断价值。方法 100例慢性重型乙型肝炎(CSHB)患者采用免疫组化二步法检测CMV-pp65抗原、荧光定量PCR法检测CMV-DNA及酶联免疫吸附反应法(ELISA)检测CMV-IgM抗体,以CMV-pp65抗原为对照,分析比较不同检测方法的差异性。结果 100例CSHB患者CMV-DNA阳性27例,阳性率为27%(27/100);CMVpp65抗原阳性45例,阳性率为45%(45/100);差异有统计学意义(P<0.05)。CMV-IgM抗体阳性4例,阳性率为4%(4/100),明显低于CMV-pp65抗原和CMV-DNA阳性率(均P<0.05)。CMV-pp65与CMVDNA诊断一致性分析采用Kappa检验,Kappa值为0.483,在0.4~0.7之间,表示吻合程度一般。CMVDNA诊断巨细胞病毒感染的灵敏度为0.486,特异度为0.906;CMV-IgM抗体诊断巨细胞病毒感染的灵敏度为0.064;特异度为0.981。CMV-DNA诊断巨细胞病毒感染的ROC曲线下面积(AUC)为0.687,P=0.001;IgM抗体诊断巨细胞病毒感染的AUC为0.522,P=0.699。结论 CMV-DNA诊断慢性重型乙型肝炎患者合并活动性巨细胞病毒感染的价值不如CMV-pp65抗原,但CMV-DNA可作为CMV-pp65抗原诊断的对照和补充,而CMV-IgM抗体无诊断价值。

关键词：巨细胞病毒慢性重型乙型肝炎 CMV-pp65抗原 CMV-DNA CMV-IgM抗体

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Biomarkers of aging

引用

Science China(Life Sciences) 2023年第5期66卷 893-1066页

作者： Aging Biomarker Consortium Hainan Bao Jiani Cao Mengting Chen Min Chen Wei Chen Xiao Chen Yanhao Chen Yu Chen Yutian Chen Zhiyang Chen Jagadish K Chhetri Yingjie Ding Junlin Feng Jun Guo Mengmeng Guo Chuting He Yujuan Jia Haiping Jiang Ying Jing dingfeng Li Jiaming Li Jingyi Li Qinhao Liang Rui Liang Feng Liu Xiaoqian Liu Zuojun Liu Oscar Junhong Luo Jianwei lv Jingyi Ma Kehang Mao Jiawei Nie Xinhua Qiao Xinpei Sun Xiaoqiang Tang Jianfang Wang Qiaoran Wang Siyuan Wang Xuan Wang Yaning Wang Yuhan Wang Rimo Wu Kai Xia Fu-Hui Xiao Lingyan Xu Yingying Xu Haoteng Yan Liang Yang Ruici Yang Yuanxin Yang Yilin Ying Le Zhang Weiwei Zhang Wenwan Zhang Xing Zhang Zhuo Zhang Min Zhou Rui Zhou Qingchen Zhu Zhengmao Zhu Feng Cao Zhongwei Cao Piu Chan Chang Chen Guobing Chen Hou-Zao Chen Jun Chen Weimin Ci Bi-Sen Ding Qiurong Ding Feng Gao Jing-Dong JHan Kai Huang Zhenyu Ju Qing-Peng Kong Ji Li Jian Li Xin Li Baohua Liu Feng Liu Lin Liu Qiang Liu Qiang Liu Xingguo Liu Yong Liu Xianghang Luo Shuai Ma Xinran Ma Zhiyong Mao Jing Nie Yaojin Peng Jing Qu Jie Ren Ruibao Ren Moshi Song Zhou Songyang Yi Eve Sun Yu Sun Mei Tian Shusen Wang Si Wang Xia Wang Xiaoning Wang Yan-Jiang Wang Yunfang Wang Catherine CL Wong Andy Peng Xiang Yichuan Xiao Zhengwei Xie Daichao Xu Jing Ye Rui Yue Cuntai Zhang Hongbo Zhang Liang Zhang Weiqi Zhang Yong Zhang Yun-Wu Zhang Zhuohua Zhang Tongbiao Zhao Yuzheng Zhao Dahai Zhu Weiguo Zou Gang Pei Guang-Hui Liu Aging Biomarker Consortium(ABC) Beijing 100101China CAS Key Laboratory of Genomic and Precision Medicine Beijing Institute of GenomicsChinese Academy of Sciences and China National Center for BioinformationBeijing 100101China State Key Laboratory of Stem Cell and Reproductive Biology Institute of ZoologyChinese Academy of SciencesBeijing 100101China Department of Dermatology Xiangya HospitalCentral South UniversityChangsha 410008China Hunan Key Laboratory of Aging Biology Xiangya HospitalCentral South UniversityChangsha 410008China National Clinical Research Center for Geriatric Disorders Xiangya HospitalCentral South UniversityChangsha 410008China Clinic Center of Human Gene Research Union HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430022China Hubei Clinical Research Center of Metabolic and Cardiovascular Disease Huazhong University of Science and TechnologyWuhan 430022China Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging Huazhong University of Science and TechnologyWuhan 430022China Stem Cell Translational Research Center Tongji HospitalTongji University School of MedicineShanghai 200065China Department of Nuclear Medicine Daping HospitalThird Military Medical UniversityChongqing 400042China CAS Key Laboratory of Nutrition Metabolism and Food SafetyShanghai Institute of Nutrition and HealthUniversity of Chinese Academy of SciencesChinese Academy of SciencesShanghai 200031China Shanghai Key Laboratory of Maternal Fetal Medicine Clinical and Translational Research Center of Shanghai First Maternity and Infant HospitalFrontier Science Center for Stem Cell ResearchShanghai Key Laboratory of Signaling and Disease ResearchSchool of Life Sciences and TechnologyTongji UniversityShanghai 200092China The Department of Endovascular Surgery The First Affiliated Hospital of Zhengzhou UniversityZhengzhou 450052China Key Laboratory of Regenerative Medicine of Ministry of Education Institute of Ageing and Regenerative MedicineJ

Aging biomarkers are a combination of biological parameters to(i)assess age-related changes,(ii)track the physiological aging process,and(iii)predict the transition into a pathological status.Although a broad spectrum of aging biomarkers has been developed,their potential uses and limitations remain poorly characterized.An immediate goal of biomarkers is to help us answer the following three fundamental questions in aging research:How old are we?Why do we get old?And how can we age slower?This review aims to address this need.Here,we summarize our current knowledge of biomarkers developed for cellular,organ,and organismal levels of aging,comprising six pillars:physiological characteristics,medical imaging,histological features,cellular alterations,molecular changes,and secretory factors.To fulfill all these requisites,we propose that aging biomarkers should qualify for being specific,systemic,and clinically relevant.

关键词： aging senescence biomarker clock

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：